:max_bytes(150000):strip_icc():focal(749x0:751x2)/gpl-1-jabs-052226-1-010a064224da4f85bf4c6ea0952739c8.jpg)
new glp 1 GLP-1 Weight Loss Drugs May Reduce Chance of Cancer Progressing, Study Finds New GLP-1 Outperforms Oral Semaglutide
Description
Statin-associated muscular and renal adverse events: Data mining of the public version of the FDA adverse event reporting system
This could be as simple as walking or doing household chores
This combination therapy results in enhanced weight loss with fewer cravings, even fewer gastrointestinal side effects (anecdotally, weve had none at all!), maintained muscle mass, and, most importantly, increased energy
Maximum Weight Loss Potential (Future) Amycretin Phase 1b/2a showed up to 24.3% weight loss at 36 weeks with no plateau, suggesting even greater loss with longer treatment
